Innoviva (INVA) EBT (2010 - 2026)
Innoviva (INVA) posted EBT of $234.6 million for Q1 2026, up 1472.36% on a QoQ basis from -$17.1 million in Q4 2025, and up 707.85% year-over-year from $29.0 million in Q1 2025.
Innoviva (INVA) EBT (2010 - 2026) Analysis & Trends
Innoviva's EBT history runs 17 years deep, the most recent figure standing at $234.6 million for Q1 2026.
- Quarterly EBT rose 707.85% year-over-year to $234.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $421.9 million (up 622.71% YoY) and the FY2025 annual result came in at $326.9 million, up 1257061.54% from the prior year.
- EBT was $234.6 million for Q1 2026 at Innoviva, up from -$17.1 million in the prior quarter.
- Across five years, EBT topped out at $351.6 million in Q3 2022 and bottomed at -$175.8 million in Q4 2023.
- A 5-year average of $46.5 million and a median of $20.5 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2023 — EBT sank 1005.62% — and 2025, when it surged 938.49%.
- Innoviva's EBT stood at -$15.9 million in 2022, then sank by 1005.62% to -$175.8 million in 2023, then surged by 91.16% to -$15.5 million in 2024, then fell by 9.99% to -$17.1 million in 2025, then jumped by 1472.36% to $234.6 million in 2026.
- Business Quant data shows INVA's EBT at $234.6 million in Q1 2026, -$17.1 million in Q4 2025, and $131.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Innoviva | 1.59 Bn | 983.20 Mn | 75.83 Mn | 234.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 234.56 Mn |
| Dec 31, 2025 | -17.09 Mn |
| Sep 30, 2025 | 131.83 Mn |
| Jun 30, 2025 | 72.60 Mn |
| Mar 31, 2025 | -38.59 Mn |
| Dec 31, 2024 | -15.54 Mn |
| Sep 30, 2024 | 12.69 Mn |
| Jun 30, 2024 | -39.28 Mn |
| Mar 31, 2024 | 45.12 Mn |
| Dec 31, 2023 | -175.83 Mn |
| Sep 30, 2023 | 132.90 Mn |
| Jun 30, 2023 | 5.81 Mn |
| Mar 31, 2023 | 41.14 Mn |
| Dec 31, 2022 | -15.90 Mn |
| Sep 30, 2022 | 351.64 Mn |
| Jun 30, 2022 | 20.50 Mn |
| Mar 31, 2022 | 44.72 Mn |
| Dec 31, 2021 | -44.88 Mn |
| Sep 30, 2021 | 388.79 Mn |
| Jun 30, 2021 | 136.18 Mn |